Conclusions To conclude, the present study favored the realization of the cytoprotection concept by using the stable pentadecapeptide BPC 157, as a prototypical cytoprotective agent (reviewed [4,5,6]), to cure pulmonary arterial hypertension
In his office, he informed me that it appeared that my T levels were indeed below the average for a man of my age and that replacement therapy was indicated, if I desired
Notably, TCM compound formulas remain understudied in this context, representing a critical avenue for future DN therapeutic development
Progression through various disease stages in cirrhosis is fraught with complications related to portal hypertension and chronic liver failure, such as acute variceal bleeding, ascites, hydrothorax, hepatic encephalopathy (HE), life-threatening infections, and extrahepatic organ failure, such as hepatorenal syndrome and additionally, hepatocellular carcinoma (2)